Infectious Respiratory Disease Diagnostics Market (By Product Type: Instruments, Consumables, Services; By Sample Type: Saliva, Nasopharyngeal Swabs, Anterior Nasal Region, Blood, Others; By Application: COVID-19, Influenza, RSV (Respiratory Syncytial Virus), Tuberculosis, Streptococcus Testing, Other; By Technology: Immunoassay, Molecular Diagnostics, Microbiology, Other) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Infectious Respiratory Disease Diagnostics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Infectious Respiratory Disease Diagnostics Market Revenue and Volume, by Product Type, 2023-2032
8.1.1. Instruments
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Consumables
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Services
8.1.3.1. Market Revenue and Forecast (2020-2032)
9.1. Infectious Respiratory Disease Diagnostics Market Revenue and Volume, by Sample Type, 2023-2032
9.1.1. Saliva
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Nasopharyngeal Swabs (NPS)
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Anterior Nasal Region
9.1.3.1. Market Revenue and Forecast (2020-2032)
9.1.4. Blood
9.1.4.1. Market Revenue and Forecast (2020-2032)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2020-2032)
10.1. Infectious Respiratory Disease Diagnostics Market Revenue and Volume, by Application, 2023-2032
10.1.1. COVID-19
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Influenza
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. RSV (Respiratory Syncytial Virus)
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Tuberculosis
10.1.4.1. Market Revenue and Forecast (2020-2032)
10.1.5. Streptococcus Testing
10.1.5.1. Market Revenue and Forecast (2020-2032)
10.1.6. Other
10.1.6.1. Market Revenue and Forecast (2020-2032)
11.1. Infectious Respiratory Disease Diagnostics Market Revenue and Volume, by Technology, 2023-2032
11.1.1. Immunoassay
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Molecular Diagnostics
11.1.2.1. Market Revenue and Forecast (2020-2032)
11.1.3. Microbiology
11.1.3.1. Market Revenue and Forecast (2020-2032)
11.1.4. Other
11.1.4.1. Market Revenue and Forecast (2020-2032)
12.1. North America
12.1.1. Market Revenue and Forecast, by Product Type (2020-2032)
12.1.2. Market Revenue and Forecast, by Sample Type (2020-2032)
12.1.3. Market Revenue and Forecast, by Application (2020-2032)
12.1.4. Market Revenue and Forecast, by Technology (2020-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product Type (2020-2032)
12.1.5.2. Market Revenue and Forecast, by Sample Type (2020-2032)
12.1.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.1.5.4. Market Revenue and Forecast, by Technology (2020-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product Type (2020-2032)
12.1.6.2. Market Revenue and Forecast, by Sample Type (2020-2032)
12.1.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.1.6.4. Market Revenue and Forecast, by Technology (2020-2032)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product Type (2020-2032)
12.2.2. Market Revenue and Forecast, by Sample Type (2020-2032)
12.2.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.4. Market Revenue and Forecast, by Technology (2020-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product Type (2020-2032)
12.2.5.2. Market Revenue and Forecast, by Sample Type (2020-2032)
12.2.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.5.4. Market Revenue and Forecast, by Technology (2020-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product Type (2020-2032)
12.2.6.2. Market Revenue and Forecast, by Sample Type (2020-2032)
12.2.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.6.4. Market Revenue and Forecast, by Technology (2020-2032)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product Type (2020-2032)
12.2.7.2. Market Revenue and Forecast, by Sample Type (2020-2032)
12.2.7.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.7.4. Market Revenue and Forecast, by Technology (2020-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product Type (2020-2032)
12.2.8.2. Market Revenue and Forecast, by Sample Type (2020-2032)
12.2.8.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.8.4. Market Revenue and Forecast, by Technology (2020-2032)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product Type (2020-2032)
12.3.2. Market Revenue and Forecast, by Sample Type (2020-2032)
12.3.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.4. Market Revenue and Forecast, by Technology (2020-2032)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product Type (2020-2032)
12.3.5.2. Market Revenue and Forecast, by Sample Type (2020-2032)
12.3.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.5.4. Market Revenue and Forecast, by Technology (2020-2032)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product Type (2020-2032)
12.3.6.2. Market Revenue and Forecast, by Sample Type (2020-2032)
12.3.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.6.4. Market Revenue and Forecast, by Technology (2020-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product Type (2020-2032)
12.3.7.2. Market Revenue and Forecast, by Sample Type (2020-2032)
12.3.7.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.7.4. Market Revenue and Forecast, by Technology (2020-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product Type (2020-2032)
12.3.8.2. Market Revenue and Forecast, by Sample Type (2020-2032)
12.3.8.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.8.4. Market Revenue and Forecast, by Technology (2020-2032)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product Type (2020-2032)
12.4.2. Market Revenue and Forecast, by Sample Type (2020-2032)
12.4.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.4. Market Revenue and Forecast, by Technology (2020-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product Type (2020-2032)
12.4.5.2. Market Revenue and Forecast, by Sample Type (2020-2032)
12.4.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.5.4. Market Revenue and Forecast, by Technology (2020-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product Type (2020-2032)
12.4.6.2. Market Revenue and Forecast, by Sample Type (2020-2032)
12.4.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.6.4. Market Revenue and Forecast, by Technology (2020-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product Type (2020-2032)
12.4.7.2. Market Revenue and Forecast, by Sample Type (2020-2032)
12.4.7.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.7.4. Market Revenue and Forecast, by Technology (2020-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product Type (2020-2032)
12.4.8.2. Market Revenue and Forecast, by Sample Type (2020-2032)
12.4.8.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.8.4. Market Revenue and Forecast, by Technology (2020-2032)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product Type (2020-2032)
12.5.2. Market Revenue and Forecast, by Sample Type (2020-2032)
12.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.5.4. Market Revenue and Forecast, by Technology (2020-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product Type (2020-2032)
12.5.5.2. Market Revenue and Forecast, by Sample Type (2020-2032)
12.5.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.5.5.4. Market Revenue and Forecast, by Technology (2020-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product Type (2020-2032)
12.5.6.2. Market Revenue and Forecast, by Sample Type (2020-2032)
12.5.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.5.6.4. Market Revenue and Forecast, by Technology (2020-2032)
13.1. F. Hoffmann-La Roche Ltd.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Abbott Laboratories
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Becton, Dickinson and Company
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Thermo Fisher Scientific Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Siemens Healthineers AG
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. QIAGEN N.V.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Bio-Rad Laboratories, Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Cepheid (Danaher Corporation)
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Hologic, Inc.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Luminex Corporation
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample